We hence evaluated the impact of the PI3Ki on C5a and IL-8 release after 24 h of stimulation (Supplementary Figure 2) as complement activation and IL-8 release are key events in the effector phase of EBA and other pemphigoid diseases (21, 47–49). This evidence concerns the gene CXCL8 and acquired epidermolysis bullosa.